A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole against invasive mold disease in cancer patients with less adverse effects. Researchers will present phase III data on this new drug.
Kieren Marr, Johns Hopkins University
Andrew Ullmann, Julius Maximilians University
Ещё видео!